| Breakdown | TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 25.95M | 25.87M | 29.80M | 38.25M | 26.99M | 21.37M |
| Gross Profit | 20.54M | 21.64M | 23.03M | 30.19M | 20.72M | 17.24M |
| EBITDA | 15.79M | 16.32M | 18.83M | 25.84M | 16.75M | 13.29M |
| Net Income | 14.16M | 15.06M | 17.12M | 22.69M | 14.51M | 11.69M |
Balance Sheet | ||||||
| Total Assets | 59.96M | 64.28M | 66.78M | 69.26M | 67.47M | 72.50M |
| Cash, Cash Equivalents and Short-Term Investments | 20.57M | 21.73M | 22.20M | 17.18M | 31.29M | 18.11M |
| Total Debt | 1.71M | 921.23K | 355.15K | 518.71K | 602.14K | 731.73K |
| Total Liabilities | 1.67M | 2.01M | 1.21M | 2.18M | 2.90M | 1.61M |
| Stockholders Equity | 58.30M | 62.27M | 65.57M | 67.08M | 64.57M | 70.89M |
Cash Flow | ||||||
| Free Cash Flow | 12.38M | 13.05M | 18.23M | 18.16M | 12.02M | 13.30M |
| Operating Cash Flow | 14.65M | 14.31M | 18.25M | 19.09M | 12.50M | 13.36M |
| Investing Cash Flow | 2.62M | 2.67M | 9.58M | -8.53M | 7.02M | 8.42M |
| Financing Cash Flow | -19.35M | -19.23M | -19.21M | -19.34M | -19.50M | -19.43M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
81 Outperform | $325.54M | 21.20 | 23.47% | 6.28% | -9.48% | -14.28% | |
66 Neutral | $271.96M | -11.32 | 1.74% | ― | -10.74% | ― | |
61 Neutral | $37.18B | 12.37 | -10.20% | 1.83% | 8.50% | -7.62% | |
60 Neutral | $214.79M | -357.39 | -0.80% | ― | -0.41% | -134.49% | |
57 Neutral | $3.58B | ― | -10.41% | ― | -4.54% | -119.39% | |
49 Neutral | $234.28M | -41.41 | -9.33% | ― | 307.44% | 14.77% | |
45 Neutral | $748.47M | -1.50 | 1017.75% | ― | ― | ― |